In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
We determined the in vitro susceptibility of four aminoglycosides, which are not of the 4,6-disubstituted deoxystreptamine (DOS) subclass against a collection of carbapenem-resistant Enterobacteriaceae (CRE). CRE clinical strains (n = 134) were collected from multiple hospitals in China and carried...
Main Authors: | Ya Hu, Lu Liu, Xiaoxia Zhang, Yu Feng, Zhiyong Zong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.02275/full |
Similar Items
-
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin
by: EFSA Panel on Biological Hazards (BIOHAZ), et al.
Published: (2021-10-01) -
In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
by: Mingju Hao, et al.
Published: (2020-03-01) -
In vitro activity of novel apramycin-dextran nanoparticles and free apramycin against selected Dutch and Pakistani Klebsiella pneumonia isolates
by: Nagina Atlas, et al.
Published: (2023-12-01) -
Antinociceptive potency of aminoglycoside antibiotics and magnesium chloride: a comparative study on models of phasic and incisional pain in rats
by: W.A. Prado, et al.
Published: (2002-03-01) -
Parallel G-quadruplex recognition by neomycin
by: Nihar Ranjan, et al.
Published: (2023-08-01)